Discover how ACE inhibitors, commonly prescribed for blood pressure, can significantly reduce heart attack damage by limiting infarct size.
Exploring why adding urapidil to ACE inhibitors provides no benefit for chronic congestive heart failure patients, based on placebo-controlled clinical trial results.
Explore the fascinating battle between ACE Inhibitors and Sartans in treating heart failure, their mechanisms, and clinical evidence.